The University of Chicago Header Logo

Connection

Peter H. O'Donnell to Immunoglobulins, Intravenous

Back to Details
This is a "connection" page, showing publications Peter H. O'Donnell has written about Immunoglobulins, Intravenous.
Peter H. O'Donnell
Connection Strength
0.034
Immunoglobulins, Intravenous
  1. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial. Lancet. 2016 May 07; 387(10031):1909-20.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.